In the last trading session, 0.71 million Edwards Lifesciences Corp (NYSE:EW) shares changed hands as the company’s beta touched 1.08. With the company’s per share price at $87.18 changed hands at -$2.87 or -3.19% during last session, the market valuation stood at $52.42B. EW’s last price was a discount, traded about -10.25% off its 52-week high of $96.12. The share price had its 52-week low at $60.57, which suggests the last value was 30.52% up since then. When we look at Edwards Lifesciences Corp’s average trading volume, we note the 10-day average is N/A shares, with the 3-month average coming to 4.03 million.

Edwards Lifesciences Corp (NYSE:EW) trade information

Instantly EW was in red as seen at the end of in last trading. With action -4.74%, the performance over the past five days has been red. The drop to weekly highs of 92.99 on N/A, N/A subtracted -3.19% to the stock’s daily price. The company’s shares are showing year-to-date upside of 14.33%, with the 5-day performance at -4.74% in the red. However, in the 30-day time frame, Edwards Lifesciences Corp (NYSE:EW) is -6.11% down. Looking at the short shares, we see there were N/A shares sold at short interest cover period of N/A days.

Edwards Lifesciences Corp (EW) estimates and forecasts

Data shows that the Edwards Lifesciences Corp share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 22.32% over the past 6 months, a 9.96% in annual growth rate that is considerably lower than the industry average of 14.50%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 15.35%. The 2024 estimates are for Edwards Lifesciences Corp earnings to increase by 9.73%, but the outlook for the next 5-year period is at 9.34% per year.